view article
Figure 1
Compounds structurally similar to the title compound, (a) 6-(indol-2-yl)pyridine-3-sulfonamides and (b) 4-(indol-2-yl)benzene sulfonamides, reported to inhibit hepatitis C virus NS4B.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Volume 76| Part 7| July 2020| Pages 1018-1021
https://doi.org/10.1107/S2056989020007185
Follow Acta Cryst. E
Sign up for e-alerts
E-alerts
Follow Acta Cryst. on Twitter
Twitter
Follow us on facebook
Facebook
Sign up for RSS feeds
RSS